NIH-funded research NIH-funded research

Exploring how certain genes affect brain cell activity and fat processing in aging and Alzheimer's disease

Official title: Investigating the effects of APOE and APOE-related AD risk genes on human microglia activity and lipid metabolism in aging and disease

Funded at Icahn School of Medicine at Mount Sinai · NIH-10900992 · Data updated 2026-11-12

This study is looking at how certain genes, especially APOE, affect brain cells that help keep our brains healthy as we age and deal with Alzheimer's disease, with the hope of finding new ways to treat or prevent the condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$745,765
NIH project number1R56AG081417-01
Project IDNIH-10900992 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include older adults and individuals at risk for Alzheimer's disease, particularly those with genetic predispositions.

Less likely to help

Patients with early-stage Alzheimer's disease or those without genetic risk factors for the condition may not benefit from this research.

What this research studies

This research investigates the role of specific genes, particularly APOE, in how brain cells called microglia respond to aging and Alzheimer's disease. It focuses on understanding how these cells manage cholesterol and lipid levels in the brain, which is crucial for maintaining brain health. By examining the genetic factors that influence microglial activity, the research aims to uncover potential therapeutic targets for Alzheimer's disease. Patients may benefit from insights that could lead to new treatments or preventive strategies for Alzheimer's.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches for Alzheimer's disease and improve brain health in aging individuals.

How similar studies have gone: Previous research has shown promising results in understanding the role of APOE in Alzheimer's disease, indicating that this approach has potential for significant findings.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Marcora, Edoardo — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Marcora, Edoardo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.